Potential Utility and Limitations of Thyroid Cancer Cell Lines as Models for Studying Thyroid Cancer-Reference-Cited by-同舟云学术

Potential Utility and Limitations of Thyroid Cancer Cell Lines as Models for Studying Thyroid Cancer

Published:2009-12 Issue:12 Volume:19 Page:1333-1342
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Pilli Tania¹,Prasad Kanteti V.¹,Jayarama Shankar¹,Pacini Furio²,Prabhakar Bellur S.¹

Affiliation:

1. Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.

2. Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism, and Biochemistry, University of Siena, Siena, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2009.0195

Reference80 articles.

1. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

2. Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer Committee

3. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine

4. Gene Expression Profiling Identifies Platelet-Derived Growth Factor as a Diagnostic Molecular Marker for Papillary Thyroid Carcinoma

5. Diagnostic and Prognostic Value of Cell-cycle Regulatory Genes in Malignant Thyroid Neoplasms

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines;Cancers;2024-07-21

2. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [⁸⁹Zr]Zr-TR1402;Molecular Pharmaceutics;2024-07-08

3. Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives;Panminerva Medica;2024-06

4. Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines;2024-04-03

5. CD73 mitigates ZEB1 expression in papillary thyroid carcinoma;Cell Communication and Signaling;2024-02-22